Monsanto Australia Limited
Canola (Brassica napus L.)
This licence allows Monsanto Australia Limited to conduct a limited and controlled release of canola genetically modified for herbicide tolerance. The dicamba-tolerant canola line proposed for release contains a gene from a soil bacterium that will confer tolerance to dicamba herbicide. The trial may be conducted at up to 15 sites with a maximum combined area of 30 ha in 2020, increasing to 20 sites with a maximum combined area of 100 ha in 2023.
The trial is to assess the performance of the GM canola under field conditions in all canola growing areas of Australia. The GM canola grown in this field trial would not be used in human food or animal feed. There are strict licence conditions to minimise dispersal of the GMOs and GM pollen from the trial sites, to securely transport and store the GM canola, and to inspect the sites at the end of the trial to ensure that the GM plants are destroyed.
The risk analysis for this application was carried out in accordance with the Regulator’s Risk Analysis Framework.
You can find out more about canola and how it is farmed in Australia in our biology document.
Outlines the Regulator’s decision to issue a licence following the assessment of this application.
FAQs on the licence application and the Regulator’s decision to issue a licence for this application.
A summary of the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.
The final risk assessment and management plan prepared to support the Regulator's decision. It describes the GMO(s) and proposed work with the GMO(s) and provides an assessment of potential risks posed by the GMO(s). It also includes a summary of submissions received during the public consultation process.